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Introduction
Apical hypertrophic cardiomyopathy (ApHCM) is a unique
form of hypertrophic cardiomyopathy (HCM), in which
the hypertrophy of myocardium predominantly involves
the apex of the left ventricle (LV). Although studies have
found that ApHCM has a benign prognosis in terms of
cardiovascular mortality,1)2) one third of ApHCM patients
may develop unfavorable clinical events and potentially
life-threatening complications, such as myocardial infarction,
atrial fibrillation, and stroke.2) Many of the clinical and
pathophysiological features of HCM result from a complex
disturbance of diastolic function.3)4-9) However, changes in
diastolic function during exercise in patients with ApHCM
are not well-known. Recently, the ratio of the mitral inflow
and the annular velocity to stroke volume (E/E’/SV) was
used as an index of diastolic elastance (Ed).10) However, in
patients with ApHCM, the change of Ed during exercise
has not been evaluated. We hypothesized that Ed during
exercise would be abnormal in patients with ApHCM.
Methods
Study Population
Mitral inflow and septal mitral annular velocities were
measured at rest and during graded supine bicycle exercise
(25 W, 3-minute increments) in 15 patients with ApHCM
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Background : The ratio of mitral inflow (E) and annular velocity (E’) to stroke volume (E/E’/SV) has been used as
an index of diastolic elastance (Ed). However, its change during exercise has not been evaluated. We hypothesized that
Ed values obtained during exercise would be abnormal in patients with apical hypertrophic cardiomyopathy (ApHCM).
Methods : Ed was measured at rest and during graded supine bicycle exercise (25 Watts, 3 minute increments) in 15
patients with ApHCM (12 male; mean age, 57 years) and in 15 age- and gender-matched control subjects.
Results : Ed was not significantly different at rest and during 25 W of exercise. However, Ed was significantly higher
at 50 W of exercise in patients with ApHCM compared to control subjects (0.21±0.05 vs. 0.15±0.04 cm/s, p=0.0059).
There was significant positive correlation between the magnitude of change in proBNP levels during exercise and the change
of Ed from rest to 50 W of exercise (r2=0.69, p＜0.0001).
Conclusion : Noninvasively-determined Ed was similar at rest and during mild exercise between patients with ApHCM
and control subjects. However, Ed was significantly higher during moderate exercise in ApHCM patients, suggesting a
dynamic change in LV stiffness during exercise in these patients.
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(12 males; mean age, 57 years) and in 15 age- and gender-
matched control subjects. Of the patients with ApHCM,
6 patients were taking calcium channel blockers and 7 patients
were taking beta-blockers. Angiotensin receptor blockers
were being taken by 7 patients and 1 patient was taking
diuretics. However, all medications were withheld before
exercise echocardiography. Seven patients were in New York
Heart Association class 2 symptom status at the time of
evaluation. Study approval was obtained from the Institutional
Review Board of Yonsei University College of Medicine.
Two-dimensional and exercise Doppler
echocardiography (Diastolic stress
echocardiography)11)
Standard two-dimensional measurements (LV diastolic
and systolic dimensions, ventricular septum and posterior
wall thickness, left atrial volume, and LV outflow tract
diameter) were obtained with the patient in the left lateral
position. The LV ejection fraction (EF) was calculated by
the modified Quinones method.12) Left atrial volume was
measured by the prolate ellipsoid method.13)14) After obtaining
resting images from the standard parasternal and apical
views, a multistage supine bicycle exercise test was performed
with a variable load bicycle ergometer (Medical Positioning,
Inc., Kansas City, Missouri). Patients pedaled at a constant
speed, beginning at a workload of 25 Watts with a 25-Watt
incremental increase every 3 minutes. Echocardiography
was performed using a GE Vingmed System 7 ultrasound
system with a 2.5-MHz transducer while the patient was
at rest, each stage of exercise, and during recovery, as described
in the following sequential steps. From the apical window,
a 1-2 mm pulsed Doppler sample volume was placed at
the mitral valve tip, and mitral flow velocities from 5 to
10 cardiac cycles were recorded. The mitral inflow velocities
were traced and the following variables were obtained:
peak velocity of early (E) and late (A) stage filling, and the
E wave velocity deceleration time. If measurable, the tricuspid
regurgitant jet velocity was also obtained to estimate pulmonary
artery systolic pressure by using continuous-wave Doppler.
Stroke volume (SV) was measured from the LV outflow
tract diameter and the pulse wave Doppler signal as described
previously.15) Mitral annular velocity was measured by tissue
Doppler imaging using the pulsed wave Doppler mode.
The filter was set to exclude high frequency signal and the
Nyquist limit was adjusted to a range of 15 to 20 cm/s. Gain
and sample volume were minimized to allow for a clear
tissue signal with minimal background noise. Early diastolic
(E’) and systolic (S’) velocities of the mitral annulus were
measured from the apical 4-chamber view with a 2- to 5-mm
sample volume placed at the septal corner of the mitral
annulus. To provide a continuous variable that might estimate
Ed, the ratio of E to E’ was used as an estimation of mean
left atrial pressure (E/E’).16-18) The operant Ed was then
estimated as E/E’ divided by the volume of filling during
diastole, assuming the absence of significant aortic regurgitation
(SV).10) These measurements were performed in the same
sequence at baseline, during each stage of exercise, and at
recovery. All data were stored digitally, and measurements
were made at the completion of each study. Two-dimensional
echocardiographic images from apical views at rest and during
exercise were acquired, digitized, recorded, and analyzed
for the analysis of wall motion.
Measurement of proBNP levels
Blood samples for proBNP analysis were drawn at rest
and immediately after peak exercise. Samples were stored
at 4。C and analyzed within 4 hours of the blood draw. Prior
to analysis, each tube was inverted several times to ensure
homogeneity. The whole blood was then analyzed in triplicate
by an electrochemiluminescence immunoassay method for
proBNP levels (Elecsys proBNP, Roche Diagnostics, Basel,
Switzerland).
Statistical Analysis 
Continuous variables were summarized as a mean±standard
deviation. Categorical variables were summarized as a percentage
of the group total. The relationship between proBNP level
and Ed was evaluated with linear regression analysis. In this
analysis, log-transformed proBNP values were used because
the proBNP distribution was positively skewed. The change
in proBNP levels during exercise were also compared with
the change in Ed values during exercise by linear regression
analysis. Statistical significance was defined as＜0.05.
Results
Baseline echocardiographic findings
Patients with ApHCM had thicker interventricular septums
and posterior walls. The left atrial volume index was significantly
larger in ApHCM patients compared to the control subjects.
Although LVEF at rest was higher in ApHCM patients
compared to control subjects with a borderline significance
(72±5 vs. 68±5, p=0.051), S’ at rest was significantly lower in
patients with ApHCM (6.2±0.9 vs. 7.0±1.0 cm/s, p=0.028),
suggesting abnormal LV longitudinal contractions. There were
no significant differences in mitral inflow velocities (E, A, E/A,
DT) between the two groups. SV and tricuspid regurgitation
velocity at rest were also similar between two groups (Table 1).
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Hemodynamic response to exercise
The effect of supine bicycle exercise on heart rate and blood
pressure is shown in Table 2. In both groups, heart rate,
systolic blood pressure, and diastolic blood pressure were
increased after exercise compared to when at rest. We found
no significant differences between the groups with regard
to changes in either the heart rate or the systolic and diastolic
blood pressures when at rest or during exercise (Table 2).
LV diastolic elastance at rest and with exercise
E/E’ was significantly higher both at rest and during exercise
in patients with ApHCM compared to control subjects (rest,
12.7±4.4 vs. 9.6±1.9 cm/s, p=0.021; 25 W, 14.8±4.3
vs. 11.1±2.4 cm/s, p=0.011; 50W, 14.1±3.6 vs. 10.1±
1.8 cm/s, p=0.02) (Fig. 1). However, the magnitude of change
in E/E’ from rest to exercise did not differ significantly between
the groups (from rest to 25 W, 1.9±2.8 vs. 1.3±2.4 cm/s,
p=0.58; from rest to 50 W, 1.2±2.8 vs. 0.6±1.2 cm/s,
p=0.43). SV during 25 W and 50 W of exercise, as well as
the SV increments during exercise, were similar between the
groups (Fig. 1). Furthermore, Ed was not significantly different
between groups at either rest or during mild exertion (rest,
0.19±0.05 vs. 0.17±0.05 cm/s, p=0.27; 25 W, 0.21±0.06
vs. 0.18±0.09 cm/s, p=0.31). However, during 50 W of
exercise, Ed became significantly higher in patients with
ApHCM when compared to control subjects (0.20±0.05
vs. 0.15±0.04 cm/s, p=0.006) (Fig. 2) (Table 3).
Table 1. Baseline echocardiographic results 
ApHCM Control p value
(n=15) (n=15)
LVEDD (mm) 50±3 49±4 0.78
LVESD (mm) 30±3 32±4 0.15
Ejection fraction (%) 72±5 68±5 0.051
IVS (mm) 11±1 9±1 0.0002
PW (mm) 11±1 9±2 0.021
LV mass index (g/m2) 107.4±19.6 91.5±18.5 0.064
LAVI (ml/m2) 25±6 19±5 0.013
E (m/sec) 0.64±0.20 0.61±0.14 0.57
A (m/sec) 0.61±0.11 0.71±0.15 0.053
E/A 1.1±0.3 0.9±0.3 0.17
DT (msec) 191±28 203±35 0.31
TR velocity (m/sec) 2.2±0.2 2.2±0.1 0.91
Stroke volume (ml) 68±14 61±16 0.23
E’ (cm/sec) 5.2±1.1 6.5±1.7 0.019
E/E’ 12.7±4.4 9.6±1.9 0.021
S’ (cm/sec) 6.2±0.9 7.0±1.0 0.028 
LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular
end-systolic dimension; IVS, interventricular septal thickness; PW, posterior
wall thickness; LAVI, left atrial volume index; E, peak velocity of early
diastolic filling; A, peak velocity of diastolic filling during atrial contraction;
DT, deceleration time; TR, tricuspid regurgitation; E’ early diastolic mitral
annular velocity; S’, systolic mitral annular velocity
Table 2. Hemodynamic response to exercise
ApHCM Control p value
(n=15) (n=15)
HR at rest (beats/min) 60±6 63±9 0.25
HR at 25W (beats/min) 90±13 93±10 0.42
HR at 50W (beats/min) 100±12 104±10 0.39
Systolic BP (mmHg) at rest 121±21 127±11 0.38
Systolic BP (mmHg) at 25W 145±25 142±15 0.67
Systolic BP (mmHg) at 50W 155±22 154±19 0.91
Diastolic BP (mmHg) at rest 74±11 78±7 0.30
Diastolic BP (mmHg) at 25W 86±15 87±7 0.89
Diastolic BP (mmHg) at 50W 85±11 92±10 0.083














Fig. 1. A: Change of SV in subjects when at rest to when exercising. Note the
similar SV values at rest and during exercise between the groups. B: Change of
E/E’ values in subjects when at rest to when exercising. Higher E/E’ values at rest


















ProBNP and diastolic elastance
Pro BNP levels at rest (363±221 vs. 96±217 pg/ml,
p=0.016) and at peak exercise (392±246 vs. 92±199 pg/ml,
p=0.012) were significantly higher in patients with ApHCM
compared to control subjects. Only minor changes in ProBNP
levels were found in the control group during exercise. In
contrast, proBNP levels were significantly elevated in ApHCM
patients during exercise (ΔproBNP with exercise, 29±30
vs. -4±19 pg/ml, p=0.018). The log-transformed proBNP
levels at rest showed a weak correlation with Ed at rest
(r2=0.19, p=0.053) (Fig. 3). However, there was a stronger
positive correlation between the magnitude of proBNP
change during exercise and the change in Ed values from
rest to 50 W of exercise (r2=0.69, p＜0.0001) (Fig. 4).
Discussion
The present study is, to our knowledge, the first to demon-
strate the dynamic change of ventricular stiffness in patients
with ApHCM using non-invasively-determined LV elastance.
Interestingly, LV elastance at rest and during mild exertion
did not differ between ApHCM patients and control subjects,
but LV elastance became abnormal in ApHCM patients
during moderate exertion. Additionally, the magnitude of
the increase in proBNP levels during exercise was significantly
correlated with the increase in ventricular stiffness during
exercise in ApHCM patients.
Diastolic function in ApHCM
Although extensive investigations have been made regarding
diastolic function in patients with HCM, few studies evaluated
diastolic function in patients with ApHCM. In a previous
study, we showed the presence of chronic diastolic dysfunction
in patients with ApHCM.19) In patients with diastolic heart
failure, exercise testing revealed the failure of SV increase
with exercise despite markedly elevated filling pressures.20)
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Table 3. Diastolic elastance measurements and proBNP levels
at rest and during exercise
ApHCM Control p value
(n=15) (n=15)
Ed at rest 0.19±0.05 0.17±0.05 0.27
Ed at 25 W 0.21±0.06 0.18±0.09 0.31
Ed at 50 W 0.20±0.05 0.15±0.04 0.006
ProBNP at rest (pg/ml) 363±221 96±217 0.016
ProBNP at peak exercise (pg/ml) 392±246 92±199 0.012
Ed, diastolic elastance; proBNP, N-terminal pro-brain natriuretic peptide
Fig. 2. Ed value changes when at rest and during exercise. Similar Ed values
were measured when the subjects were at rest and during 25 W of exercise,
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Fig. 3. Plot showing the relationship between the log proBNP levels and
Ed while the patients were at rest. ProBNP levels correlated with Ed at the
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Fig. 4. The relationship between the change of proBNP levels as well as
the change of Ed in subjects going from the resting state to peak exercise.
A significant positive correlation between the magnitude of change in proBNP
levels during exercise and the change of diastolic elastance from a resting
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Since Ed is the parameter that combines SV with LV filling
pressures, it can be speculated that patients with ApHCM
will have an abnormal Ed during exercise. This hypothesis
was supported by our finding that Ed became abnormal
with exercise. Abnormal Ed values during exercise in ApHCM
patients were driven by higher E/E’ values. Since SV responses
to exercise were similar between the groups, elevated filling
pressure was the primary factor responsible for increased
Ed in ApHCM patients. In severe diastolic dysfunction, SV
can not be increased in response to stress factors such as
exercise, and LV filling pressures are inevitably elevated
during exercise. We speculate that the diastolic function of
ApHCM is abnormal but not severe enough to compromise
the SV response to exercise. Therefore, the augmentation of
SV during exercise was maintained but was accompanied
by an elevation in LV filling pressure.
Change of proBNP and diastolic elastance in
ApHCM patients
BNP is released in direct proportion to the ventricular volume
expansion and pressure overload, as well as the ventricular
wall stress in patients with systolic heart failure.9)14)21) Plasma
proBNP levels have been well correlated with the LV diastolic
pressures in patients with a normal LV systolic function.22)
About 40% of the patients with ApHCM had an elevated
plasma level of proBNP, suggesting the presence of elevated
filling pressures at rest in some of the ApHCM patients.19)
However, the relationship between the concen-tration of
proBNP and ventricular stiffness in patients with ApHCM
has not been investigated. In our study, the log-transformed
proBNP levels at rest showed a borderline significant positive
correlation with the Ed values. The result of our study is
consistent with a previous study showing subjects with
higher Ed values had higher plasma BNP concentrations.10)
However, our study further demonstrates that the magnitude
of proBNP increase during exercise was significantly correlated
with the increase in ventricular stiffness during exercise.
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